多囊卵巢综合征合并胰岛素抵抗诊治专家共识

Consensus on the diagnosis and management of polycystic ovary syndrome with insulin resistance

胰岛素抵抗(IR)在多囊卵巢综合征(PCOS)的诊治中愈发受到重视。然而,目前国内外对于PCOS患者合并IR的诊断和治疗尚无统一共识。因此,本文参考最新国际指南和共识,结合中国临床实践,经充分讨论后形成该共识,旨在为PCOS合并IR患者的诊治提供相关指导和建议,以提升临床诊治水平,改善患者预后。这一共识的形成可弥补目前该领域的知识空缺,为医务人员提供科学和实用的依据,进而更好地应对PCOS合并IR的临床挑战。

Insulin resistance(IR)is increasingly recognized as a crucial aspect in the diagnosis and management of polycystic ovary syndrome(PCOS).However,a global consensus on standardized procedures for addressing IR in PCOS is currently lacking.This article seeks to fill this gap by drawing on the latest international guidelines and consensus,alongside insights from contemporary clinical practices in China.Through comprehensive discussions,this consensus is formulated with the aim of providing relevant guidance for diagnosis and treatment of PCOS in conjunction with IR.The ultimate objective is to elevate diagnostic and treatment standards and enhance patient prognosis.This consensus aspires to contribute to the field by bridging existing knowledge gaps,empowering medical professionals with a scientifically grounded and practical framework to effectively navigate the clinical challenges presented by PCOS combined with IR.